STAT3 and cholangiocarcinoma: In addition, isoliquiritigenin (ISL) [29,30], xanthoangelol, 4-hydroxyderricin [31], and xanthohumol contribute to the suppression of STAT3 expression in various cancer cells, including breast cancer, cholangiocarcinoma and pancreatic cancer [32].